Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV001822847 | SCV002072121 | likely pathogenic | not provided | 2017-07-16 | criteria provided, single submitter | clinical testing | |
Broad Center for Mendelian Genomics, |
RCV003321873 | SCV004026511 | likely pathogenic | Hyperinsulinemic hypoglycemia, familial, 1 | 2023-08-16 | criteria provided, single submitter | curation | The p.Gly1383Arg variant in ABCC8 has been reported in 2 individuals with hyperinsulinemic hypoglycemia (PMID: 20685672, 23275527), and has been identified in 0.008 (1/13146) of African/African American chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs748233295). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (Variation ID: 1338249) and has been interpreted as likely pathogenic by Genetic Services Laboratory (University of Chicago). Of the 2 affected individuals, 1 was a compound heterozygote that carried a reported pathogenic variant in unknown phase, which increases the likelihood that the p.Gly1383Arg variant is pathogenic (Variation ID: 370163; PMID: 23275527). Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. Two additional likely pathogenic variants, resulting in a different amino acid change at the same position, (p.Gly1383Ala and p.Gly1383Glu), have been reported in association with disease in ClinVar, supporting that a change at this position may not be tolerated (Variation ID: 2137010). In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for autosomal recessive hyperinsulinemic hypoglycemia. ACMG/AMP Criteria applied: PP3, PM2, PM3_supporting, PM5 (Richards 2015). |